(PharmaNewsWire.Com, April 24, 2019 ) The global cardiovascular ultrasound system market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, at a CAGR of 5.4% from 2016 to 2021. In this report, the global market is segmented on the basis of test type, technology, device display, end user, and region.
The growth of the cardiovascular ultrasound system market is propelled by increasing incidence of CVDs, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures. However, factors such as insufficient reimbursement scenario and economic impact of adopting new technologies are hindering the growth of the market.
The major key players in the cardiovascular ultrasound system market include GE Healthcare (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).
Target Audience: -Cardiovascular ultrasound system manufacturers -Cardiovascular ultrasound system distributors and wholesalers -Pharmaceutical companies -Various research and consulting firms -Research institutes -Contract manufacturing organizations (CMOs) -Original equipment manufacturers (OEMs)
Recent Developments: -In 2015, GE Healthcare signed a memorandum of understanding with the Oregon Health & Science University (U.S.) to undertake collaborative R&D studies in the field of cardiovascular imaging & treatment as well as in big data research
-In 2015, GE Healthcare launched a new 4D cardiac ultrasound software—cSound—for three new ultrasound systems, namely, VividS70, VividE90, and VividE95 in the U.S. and some countries in Europe, Asia, and LatinAmerica.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
